Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...

By Daphne Psaledakis, Simon Lewis and Elias Biryabarema WASHINGTON (Reuters) -About 1,000 doses of Gilead Sciences Inc's drug ...

Tatenda Makoni is a Zimbabwean-born medical student at the Medical College of Wisconsin whose work bridges global health and ...

The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...

Lenacapavir is a twice-yearly injectable drug produced by Gilead Sciences that is aimed at preventing HIV infection. In 2024, ...

The Department of Health said the decision reflects its mandate to ensure that all citizens have access to safe, effective, ...

BIC is an integrase strand transfer inhibitor that has a higher barrier to resistance and is only used in combination. LEN has been approved as a method of pre-exposure prophylaxis but has also been ...

Zimbabwe was selected as one of the 10 countries globally to roll out Lenacapavir, which is described as one of the most ...

Around 1,000 doses of Gilead Sciences' HIV prevention drug, lenacapavir, were sent to Zambia and Eswatini under a U.S.

South Africa takes the lead in HIV prevention with a groundbreaking twice-a-year injection being added to the Essential Medicines List.

Gilead Sciences has developed an industry-leading HIV portfolio in recent years with its megablockbuster daily treatment ...

African kingdom has accepted 15 men as part of a third-country deportation program. This program, which has been strongly ...